Informations techniques
Exploitant
OMNIVISION GmbH
Présentation
BRIMONIDINE OMNIVISION 2 mg/ml, collyre en solution en récipients unidoses - 60 récipients unidoses de 0,35 ml (CIP : 34009 301 500 3 0)
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
Hm4h1zqnQ6WcL8eN